查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1808953

生物假體市場（按產品、應用、國家和地區）－2025 年至 2032 年全球產業分析、市場規模、市場佔有率及預測

Bioprosthetics Market, By Product, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年生物假體市場規模價值 59.48 億美元，2025 年至 2032 年的複合年成長率為 4.80%。

生物假體是指利用生物材料製造義肢裝置。這些裝置通常用於替換或恢復受損或缺少的身體部位的功能。與通常由塑膠或金屬等合成材料製成的傳統義肢不同，生物義肢融入了組織或生物材料等天然元素，以更好地模擬人體部位的功能和結構。

生物假體市場-市場動態

再生醫學方法的進展

再生醫學的快速發展推動了生物假體（尤其是幹細胞療法和組織工程）的創新。這些技術能夠製造出與天然組織非常相似的生物假體裝置，進而改善整合性、功能性和患者的長期療效。例如，2024年10月，研究人員成功利用幹細胞衍生療法治療老年性黃斑部病變，顯著改善了患者的視力。這項突破展示了再生方法在開發生物假體解決方案方面的潛力，這些解決方案能夠恢復患者功能並改善生活品質。隨著再生醫學的進步，它有望在提高生物假體植入物的性能和使用壽命方面發揮重要作用，從而推動市場成長。

生物假體市場－關鍵見解

我們的研究分析師估計，2025 年至 2032 年間，全球市場將以約 4.80% 的複合年成長率成長。

根據產品細分，同種異體移植領域將在 2025 年佔據市場主導地位。

根據應用領域，預計整形外科和傷口癒合在預測期內將經歷顯著的複合年成長率。

預計北美將在 2025 年引領市場。

生物假體市場-細分分析：

全球生物假體市場根據產品、應用和地區進行細分。

市場依產品分為兩類：同種異體移植和異種移植。由於老年人口的成長和同種異體移植技術的進步，同種異體移植將在2025年佔據市場主導地位。同種異體移植是指將組織或器官從一個個體移植到另一個同種異體。全球人口老化導致心血管疾病（CVD）發生率上升，組織修復成為必要。同種異體移植假體以其優異的植入物存活率和功能性而脫穎而出，從而改善了長期療效。例如，Artivion, Inc. 的 CryoValve 主動脈同種異體移植包含完整的主動脈根部以及附著的二尖瓣前葉，提供了多種手術植入方案。

根據應用，市場分為兩類：心血管領域和整形外科及傷口癒合領域。由於微創手術需求的成長和技術進步，預計預測期內整形外科及傷口癒合領域將實現顯著的複合年成長率。根據美國整形外科醫師協會 (ASPS) 的數據，男性美容手術整體成長了 6%。此外，微創技術的實施也對該領域的成長產生了正面的影響。此外，2023 年 ASPS 手術統計數據顯示，美容手術的整體成長率為每年 5%。

生物假體市場—地理洞察

預計到2025年，北美將佔據市場主導地位。推動這一成長的因素包括心血管疾病發病率的上升以及該地區完善的醫療設施。根據美國疾病管制與預防中心的數據，心血管疾病 (CVD) 仍然是美國主要的公共衛生問題，每33秒鐘就有一人死於心血管疾病。這項令人擔憂的統計數據凸顯了心血管領域對更好生物瓣膜選擇的需求。美國市場對北美的成長做出了重大貢獻。這得歸功於美國心臟病發病率的上升、醫療支出的增加以及主要的生物製藥公司。此外，優惠的報銷政策和大量的研發投入預計將加速市場成長。

預計亞太地區在預測期內的複合年成長率將位居前列。推動這快速成長的因素包括：替代療法認知度的提升、醫療基礎設施的快速發展，以及印度和中國等發展中國家在研發方面的投入。這些國家的政府措施旨在提高醫療服務的可及性和質量，從而支持區域成長潛力。中國的「健康中國2030」規劃旨在改善健康狀況，促進長壽。這可能會推動生物義肢等先進醫療技術的普及。

生物假體市場-競爭格局：

生物假體市場競爭激烈，主要受技術創新、材料進步以及微創手術需求不斷成長的驅動。 LeMaitre Vascular, Inc.、Braile Biomedica、美敦力、Rua Life Sciences Plc（Aortech International Plc.）和LivaNova PLC（Sorin Group）憑藉其多樣化的生物假體心臟瓣膜和血管移植物產品組合，佔據了市場主導地位。這些公司透過投資研發、策略性收購和全球擴張來增強市場地位。新興公司和新創公司也紛紛進入市場，推出創新的組織工程植入物和個人化生物假體解決方案。經導管主動脈瓣置換術 (TAVR) 的日益普及、監管機構的積極核准以及心血管和骨科疾病患病率的不斷上升，正在加劇行業競爭，並加速行業創新。

最新動態：

2024年12月，印度醫療設備公司Meril Life Sciences新近推出了Myval Octapro經導管心臟瓣膜（THV），該產品已獲得經導管主動脈瓣置換術（TAVR）的CE標誌認證。

目錄

第1章：生物義肢市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 生物義肢市場產品片段
    • 生物假體市場片段（依應用）
    • 生物義肢市場（按國家/地區）
    • 生物義肢市場（按地區）
  • 競爭洞察

第3章：生物假體關鍵市場趨勢

  • 生物義肢市場促進因素
    • 市場促進因素的影響分析
  • 生物義肢市場限制
    • 市場限制的影響分析
  • 生物義肢市場機遇
  • 生物假體市場未來趨勢

第4章：生物義肢產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：生物義肢市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：生物義肢市場格局

  • 2024年生物假體市場佔有率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：生物義肢市場－依產品

  • 概述
    • 按產品細分的市佔率分析
    • 同種異體移植
    • 異種移植

第 8 章：生物義肢市場 - 按應用

  • 概述
    • 按應用細分市場佔有率分析
    • 心血管
    • 整形外科和傷口癒合

第9章：生物義肢市場－按地區分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美生物假體主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按產品）
    • 北美市場規模和預測（按應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲生物假體主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（按產品）
    • 歐洲市場規模和預測，按應用
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區生物假體主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依產品）
    • 亞太地區市場規模及預測（按應用）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲生物假體主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按產品）
    • 拉丁美洲市場規模及預測（按應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的生物假體主要製造商
    • MEA 市場規模及預測（依國家/地區）
    • MEA 市場規模及預測（依產品）
    • MEA 市場規模及預測（按應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 10 章：主要供應商分析-生物假體產業

  • 競爭基準化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司簡介
    • LeMaitre Vascular, Inc.
    • Braile Biomedica
    • Medtronic
    • Rua Life Sciences Plc (Aortech International Plc.)
    • LivaNova PLC (Sorin Group)
    • Organogenesis Inc.
    • Labcor Laboratories Ltda.
    • Humacyte Global, Inc.
    • Johnson & Johnson (Ethicon, Inc.)
    • Abbott (St. Jude Medical, Inc.)
    • Artivion, Inc. (CryoLife, Inc.)
    • Edwards Lifesciences Corporation.
    • JenaValve
    • Others

第 11 章：360 度分析師視角

第 12 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5595

Bioprosthetics Market size was valued at US$ 5,948 Million in 2024, expanding at a CAGR of 4.80% from 2025 to 2032.

Bioprosthetics is the use of biological materials in the manufacture of prosthetic devices. These devices are usually intended to replace or restore the functionality of damaged or missing body parts. Unlike traditional prosthetics, which are typically made of synthetic materials such as plastics or metals, bioprosthetics incorporate natural elements such as tissues or biomaterials to better mimic the function and structure of human body parts.

Bioprosthetics Market- Market Dynamics

Advances in regenerative medicine approaches

Rapid advances in regenerative medicine are driving innovation in bioprosthetics, particularly stem cell therapy and tissue engineering. These techniques enable the creation of bioprosthetic devices that closely resemble natural tissues, thereby improving integration, functionality, and long-term patient outcomes. For instance, in October 2024, researchers successfully used stem cell-derived therapies to treat age-related macular degeneration, significantly improving patients' vision. This breakthrough demonstrates the potential of regenerative approaches for developing bioprosthetic solutions that restore function and improve quality of life. As regenerative medicine advances, it is expected to play an important role in improving the performance and longevity of bioprosthetic implants, thereby driving market growth.

Bioprosthetics Market- Key Insights

Our research analyst estimates that the global market will grow at a CAGR of approximately 4.80% between 2025 and 2032.

Based on Product segmentation, the allograft segment dominates the market in 2025.

According to the application segment, Plastic surgery and wound healing are expected to experience significant CAGR growth during the forecast period.

North America is anticipated to lead the market in 2025.

Bioprosthetics Market- Segmentation Analysis:

The Global Bioprosthetics Market is segmented on the basis of Product, Application, and Region.

The market is divided into two categories based on Product: Allograft, and Xenograft. The allograft segment will dominate the market in 2025, owing to an increasing geriatric population and advances in allograft procedures. An allograft is a tissue or organ transplant from one individual to another of the same species. The world's aging population is contributing to an increase in CVD, necessitating tissue repair. The allograft prosthesis stands out for its excellent implant survival and functional performance, which improves long-term outcomes. For instance, Artivion, Inc.'s CryoValve AORTIC ALLOGRAFT includes a complete aortic root as well as the attached anterior mitral leaflet, providing several surgical implantation options.

The market is divided into two categories based on application: Cardiovascular, and Plastic surgery & wound healing. The plastic surgery and wound healing segment is expected to grow at a significant CAGR during the forecast period, owing to increased demand for minimally invasive surgery and technological advancement. According to the American Society of Plastic Surgeons (ASPS), overall cosmetic procedures performed on men increased by 6%. Furthermore, implementing minimally invasive techniques is having a positive impact on segment growth. Furthermore, the 2023 ASPS Procedural Statistics show that overall growth in cosmetic surgery procedures has increased by 5% per year.

Bioprosthetics Market- Geographical Insights

In 2025, North America is expected to dominate the market. Factors driving this growth include rising cardiovascular disease rates and established healthcare facilities in the region. According to the Centers for Disease Control and Prevention, cardiovascular disease (CVD) remains a major public health concern in the United States, with one person dying from it every 33 seconds. This alarming statistic highlights the need for better bioprosthetic heart valve options in the cardiovascular sector. The U.S. market has significantly contributed to growth in North America. This is due to rising heart disease, increased healthcare spending, and key biopharma companies in the country. Furthermore, favorable reimbursement policies and significant R&D investments are expected to accelerate market growth.

The Asia Pacific region is expected to have the fastest CAGR during the forecast period. This rapid growth is driven by increased awareness of alternative treatments, rapidly developing healthcare infrastructure, and increased engagement in research and development in developing countries like India and China. Government initiatives in these countries aim to improve healthcare accessibility and quality, which supports regional growth potential. China's Healthy China 2030 plan aims to improve health and promote longevity. This may lead to increased adoption of advanced medical technologies, such as bioprosthetics.

Bioprosthetics Market- Competitive Landscape:

The bioprosthetics market is highly competitive, driven by technological innovation, material advancements, and rising demand for minimally invasive procedures. LeMaitre Vascular, Inc., Braile Biomedica, Medtronic, Rua Life Sciences Plc (Aortech International Plc.), and LivaNova PLC (Sorin Group) dominate the market with a diverse portfolio of bioprosthetic heart valves and vascular grafts. These companies compete by investing in R&D, making strategic acquisitions, and expanding globally to strengthen their market position. New companies and startups are also entering the market with innovative tissue-engineered implants and personalized bioprosthetic solutions. The growing use of transcatheter aortic valve replacement (TAVR), favorable regulatory approvals, and rising prevalence of cardiovascular and orthopedic conditions are increasing competition and accelerating innovation in the industry.

Recent Developments:

In December 2024, Meril Life Sciences, an Indian medical equipment company, recently introduced the Myval Octapro transcatheter heart valve (THV), which has received CE mark approval for transcatheter aortic valve replacement (TAVR).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOPROSTHETICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • LeMaitre Vascular, Inc.
  • Braile Biomedica
  • Medtronic
  • Rua Life Sciences Plc (Aortech International Plc.)
  • LivaNova PLC (Sorin Group)
  • Organogenesis Inc.
  • Labcor Laboratories Ltda.
  • Humacyte Global, Inc.
  • Johnson & Johnson (Ethicon, Inc.)
  • Abbott (St. Jude Medical, Inc.)
  • Artivion, Inc. (CryoLife, Inc.)
  • Edwards Lifesciences Corporation.
  • JenaValve
  • Others

GLOBAL BIOPROSTHETICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Allograft
  • Xenograft

GLOBAL BIOPROSTHETICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cardiovascular
  • Plastic surgery & wound healing

GLOBAL BIOPROSTHETICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Bioprosthetics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Bioprosthetics Market Snippet by Product
    • 2.1.2. Bioprosthetics Market Snippet by Application
    • 2.1.3. Bioprosthetics Market Snippet by Country
    • 2.1.4. Bioprosthetics Market Snippet by Region
  • 2.2. Competitive Insights

3. Bioprosthetics Key Market Trends

  • 3.1. Bioprosthetics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Bioprosthetics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Bioprosthetics Market Opportunities
  • 3.4. Bioprosthetics Market Future Trends

4. Bioprosthetics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Bioprosthetics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Bioprosthetics Market Landscape

  • 6.1. Bioprosthetics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Bioprosthetics Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Allograft
    • 7.1.3. Xenograft

8. Bioprosthetics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Cardiovascular
    • 8.1.3. Plastic surgery & wound healing

9. Bioprosthetics Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Bioprosthetics Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Bioprosthetics Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7. UK
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.7.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8. France
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.8.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9. Italy
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10. Spain
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.10.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11. The Netherlands
      • 9.3.11.1. Overview
      • 9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.11.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Overview
      • 9.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.12.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13. Russia
      • 9.3.13.1. Overview
      • 9.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.13.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Bioprosthetics Key Manufacturers in Asia Pacific
    • 9.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6. China
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.6.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7. India
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11. Indonesia
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12. Thailand
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5. Latin America (LATAM)
    • 9.5.1. Overview
    • 9.5.2. Bioprosthetics Key Manufacturers in Latin America
    • 9.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa (MEA)
    • 9.6.1. Overview
    • 9.6.2. Bioprosthetics Key Manufacturers in Middle East and Africa
    • 9.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7. UAE
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.7.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Bioprosthetics Industry

  • 10.1. Competitive Benchmarking
    • 10.1.1. Competitive Dashboard
    • 10.1.2. Competitive Positioning
  • 10.2. Company Profiles
    • 10.2.1. LeMaitre Vascular, Inc.
    • 10.2.2. Braile Biomedica
    • 10.2.3. Medtronic
    • 10.2.4. Rua Life Sciences Plc (Aortech International Plc.)
    • 10.2.5. LivaNova PLC (Sorin Group)
    • 10.2.6. Organogenesis Inc.
    • 10.2.7. Labcor Laboratories Ltda.
    • 10.2.8. Humacyte Global, Inc.
    • 10.2.9. Johnson & Johnson (Ethicon, Inc.)
    • 10.2.10. Abbott (St. Jude Medical, Inc.)
    • 10.2.11. Artivion, Inc. (CryoLife, Inc.)
    • 10.2.12. Edwards Lifesciences Corporation.
    • 10.2.13. JenaValve
    • 10.2.14. Others

11. 360 Degree AnalystView

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us